Clinical Evaluation of Adherence to Migraine Preventive Medications

Clinical Evaluation of Adherence to Migraine Preventive Medications - Clinical Evaluation of Adherence to Migraine Preventive Medications

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061478

Enrollment

Registered

2026-05-19

Start date

2026-05-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients diagnosed with migraine by headache specialists according to the International Classification of Headache Disorders, 3rd edition, who are able to complete a headache diary, will be eligible. Participants must be initiating an oral preventive medication for migraine. There will be no restrictions on age or sex.

Exclusion criteria

Exclusion criteria: atients considered inappropriate for inclusion based on the clinical judgment of the attending physician.

Design outcomes

Primary

Measure	Time frame
adherance	—

Countries

Japan

Contacts

Public ContactYasushi Shibata

University of Tsukuba, Mito Medical Center, Mito Kyodo General Hospital Department of Neurosurgery/Headache Clinic

yshibata@md.tsukuba.ac.jp029231-2371

Outcome results